• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:蔡喆,潘文合.和厚朴酚泊洛沙姆F-127胶束的制备及其体外抗肿瘤研究[J].中国现代应用药学,2014,31(2):186-189.
CAI Zhe,PAN Wenhe.Honokiol/Pluronic F-127 Micelles: Preparation and Its in Vitro Anti-tumor Study[J].Chin J Mod Appl Pharm(中国现代应用药学),2014,31(2):186-189.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3061次   下载 1486 本文二维码信息
码上扫一扫!
分享到: 微信 更多
和厚朴酚泊洛沙姆F-127胶束的制备及其体外抗肿瘤研究
蔡喆, 潘文合
温州医科大学附属第二医院,浙江 温州 325000
摘要:
目的 以泊洛沙姆F-127为载体制备一种新型的和厚朴酚胶束制剂,以提高其抗肿瘤效果。方法 选用泊洛沙姆F-127为药物载体,采用自组装法制备和厚朴酚胶束制剂,通过透射电镜观察和厚朴酚胶束的形貌,采用紫外分光光度法测定载药量、药物包封率以及体外药物释放行为。采用MTT法检测和厚朴酚及其和厚朴酚胶束制剂对BGC-823人胃癌细胞的抑制作用。结果 本研究所制备的和厚朴酚胶束纳米制剂,具有壳-核的球型结构。纳米粒子分布较窄,平均粒径为28.7 nm。和厚朴酚与泊洛沙姆F-127的投料比影响胶束制剂载药量,随着和厚朴酚与泊洛沙姆F-127的投料比从1∶10增加到1∶2.5,载药胶束的载药量从(8.4±1.6)%增加到(25.7±2.7)%,而包封率维持在97%左右。体外释放结果显示和厚朴酚可以缓慢地从泊洛沙姆F-127胶束中释放出来。体外抗肿瘤实验结果显示:相比于溶液剂型的和厚朴酚,和厚朴酚/泊洛沙姆F-127胶束具有更好的体外抗BGC-823人胃癌细胞效果。结论 和厚朴酚/泊洛沙姆F-127胶束是一种新型的和厚朴酚纳米制剂,能有效提高体外抗BGC-823人胃癌细胞效果。
关键词:  泊洛沙姆  胶束  和厚朴酚  体外抗肿瘤
DOI:
分类号:R285.5
基金项目:
Honokiol/Pluronic F-127 Micelles: Preparation and Its in Vitro Anti-tumor Study
CAI Zhe, PAN Wenhe
The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
Abstract:
OBJECTIVE To develop a novel honokiol loaded pluronic F-127 micelles formulation to improve its anti-tumor capacity. METHODS Honokiol loaded pluronic F-127 micelles was developed by a self-assemble method. The developed honokiol micelles was characterized by TEM and DLS. Drug loading capacity and encapsulation effciency were measured by UV-IS spectroscopy. In vitro release of honokiol from pluronic F-127 micelles was performed in PBS solution at 37 ℃. In vitro cytotoxicity of honokiol micelles against BGC-823 cell lines was detected by MTT assay. RESULTS The developed honokiol loaded pluronic F-127 micelles with core-shell structure had mean diameter of 20-30 nm. With the increase of honokiol/pluronic F-127 feed ratio from 1∶10 to 1∶2.5, the drug loading capacity increased from (8.4±1.6)% to (25.7±2.7)% accordingly, while drug encapsulation efficiency reached nearly 97%. In vitro cytotoxicity test indicated that the developed honokiol micelles showed higher cytotoxicity against BGC-823 cells with respect to honokiol solution. CONCLUSION The developed honokiol loaded pluronic F-127 micelles is a novel honokiol nano-formualtion, that can effciently improve its anti-tumor capacity.
Key words:  泊洛沙姆  胶束  和厚朴酚  体外抗肿瘤
扫一扫关注本刊微信